The scientific board is established in March 2016 with the purpose to provide advice to the research roadmap of SkinVision to further improve the engagement of users for regular skin monitoring and the adoption of health professionals to use new technology like SkinVision as trusted source within their practice and towards their patients.
SkinVision aims to provide different personalized and science based journeys for serious skin conditions. The application offers a full chain of online solutions that will drive awareness for regular skin monitoring, self reliance of consumers and easy online access to health professionals.
The board will provide input on opportunities within:
Prof. Dr. Med. Dr. T. Ruzicka is Head of the Clinic for Dermatology in the Ludwig Maximilian University in Munich since 2006. Before 2006 he was the Head of the Dermatology Clinic of the University of Düsseldorf for many years. His medical focus is on research of and treatment for neurodermatitis, psoriasis, lichen ruber and other inflammatory skin diseases, acne as well as autoimmune diseases of the skin. Prof. Ruzicka has more than 800 publications in peer reviewed journals.
Professor Murrell is Head of the Department of Dermatology at St George Hospital, University of New South Wales, in Sydney, Australia. She specialises in novel therapeutics for skin disorders. Prof Murrell has 217 publications in peer reviewed journals with over 5.500 citations, H index 37 and i10 index of 94. She edited 6 books, serves on the editorial board of JAMA Dermatology, JEADV, Acta Derm Venereol, Int J Dermatol and is co-founding editor of the Int J Women’s Derm. She was Executive Vice President of the International Society of Dermatology (2011-13), a Board member of the Women’s Dermatologic Society (2012-16) and Chair of the American Academy of Dermatology’s World Congress Task Force (2013-16). Her research interests include Skin Cancer, Psoriasis, Eczema, Acne, Blistering disorders, pemphigus, pemphigoid and epidermolysis bullosa).
Dr. Baum is an Assistant Professor in the Department of Dermatology at the Mayo Clinic in Rochester, Minnesota. He graduated from medical school at the University of Iowa. Following his residency at the University of Iowa Hospitals and Clinics, he received fellowship training in Mohs Surgery and Cutaneous Oncology at the University of Iowa Hospitals and Clinics under the direction of Christopher Arpey. He currently enjoys a practice that focuses on cutaneous oncology, reconstruction, and resident and fellow education. His research interests include melanoma, spindlecell tumors, and squamous cell carcinoma.
"I'm excited to be part of SkinVision. The progress that is made in recognizing skin cancer with the algorithm based assessment is impressive. With the support of the SkinVision technology the health system is able to provide improved services to more patients and enables individuals to become active in staying healthy."Prof. Thomas Ruzicka, Ludwig Maximilian University, Munich